For citations:
Shlyakhto Ye.V., Arutyunov G.P., Belenkov Yu.N., Tarlovskaya E.I., Konradi A.O., Panchenko E.P., Yavelov I.S., Tereshchenko S.N., Ardashev A.V., Arutyunov A.G., Grigorieva N.Yu., Dzhunusbekova G.A., Drapkina O.M., Koziolova N.A., Komarov A.L., Kropacheva E.S., Malchikova S.V., Mitkovskaya N.P., Orlova Ya.A., Petrova M.M., Rebrov A.P., Sisakian H., Skibitsky V.V., Sugraliyev A.B., Fomin I.V., Chesnikova A.I., Shaposhnik I.I., Zhelyakov E.G., Kanorskii S.G., Kolotsey L.V., Snezhitskiy V.A. Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19. The Agreed Experts’ Position of Russian Society of Cardiology, Eurasian Association of Therapists, National Society on Atherothrombosis, Societies of Experts in Urgent Cardiology, Eurasian Arrhythmology Association. Kardiologiia. 2020;60(6):4–14. (In Russ.) https://doi.org/10.18087/cardio.2020.6.n1180